|
|
||||||||
Servicio de Cardiología, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain
| |
ABSTRACT |
|---|
|
|
|---|
To characterize the effects of ischemia on cGMP synthesis in microvascular endothelium, cultured endothelial cells from adult rat hearts were exposed to hypoxia or normoxia at pH 6.4 or 7.4. Cellular cGMP and soluble (sGC) and membrane guanylyl cyclase (mGC) activities were measured after stimulation of sGC (S-nitroso-N-acetyl-penicillamine) or mGC (urodilatin) or after no stimulation. Cell death (lactate dehydrogenase release) was negligible in all experiments. Hypoxia at pH 6.4 induced a rapid ~90% decrease in cellular cGMP after sGC and mGC stimulation. This effect was reproduced by acidosis. Hypoxia at pH 7.4 elicited a less pronounced (~50%) and slower reduction in cGMP synthesis. Reoxygenation after 2 h of hypoxia at either pH 6.4 or 7.4 normalized the response to mGC stimulation but further deteriorated the sGC response; normalization of pH rapidly reversed the effects of acidosis. At pH 7.4, the response to GC stimulation correlated well with cellular ATP. We conclude that simulated ischemia severely depresses cGMP synthesis in microvascular coronary endothelial cells through ATP depletion and acidosis without intrinsic protein alteration.
guanylyl cyclases; ATP depletion; pH; ischemia-reperfusion; nitric oxide; natriuretic factors
| |
INTRODUCTION |
|---|
|
|
|---|
AN IMPORTANT INTRACELLULAR MESSENGER is cGMP, which mediates most actions of nitric oxide (NO) and atrial natriuretic peptide (ANP). NO activates cGMP synthesis by binding to a prosthetic heme group of soluble guanylyl cyclase (sGC), whereas ANP and ANP-related peptides stimulate particulate, membrane-bound guanylyl cyclases (mGCs).
The changes induced by ischemia-reperfusion on NO availability in myocardial tissue and their consequences on different aspects of cell injury have not been completely elucidated. During myocardial reperfusion, NO may have direct toxic effects and contribute to initiate apoptosis (8), but can also have beneficial actions on platelet and leukocyte aggregation and adhesion, leukocyte migration, endothelial permeability, or microvascular function (10), and can mediate preconditioning (31). Although there are discrepant results, a vast majority of studies have found that NO donors and L-arginine, the NO synthase substrate, have a beneficial effect on myocardial ischemia-reperfusion injury (25, 37).
Recent studies have shown that this beneficial effect of NO can be mimicked by soluble cGMP analogs or by stimulation of mGC with ANP-related peptides in the heart and other tissues (1, 14, 24, 29). We have found that part of this beneficial effect can be ascribed to a protection against cardiomyocyte hypercontracture (1, 14). However, cGMP also regulates many processes crucial for the microvascular injury, such as most of the effects in which NO has been implicated [e.g., vascular permeability (12, 18) and cell adhesion (11, 26)] and the control of NO synthesis via phosphorylation of endothelial NO synthase (4). However, the effects of cGMP on ischemia-reperfusion injury have not been fully clarified. These effects could be concentration dependent. High cGMP concentration may mediate apoptosis (unpublished observations and Ref. 36), and we have found a concentration-dependent, bimodal response to urodilatin in reperfused rat and pig myocardium (29). Intriguingly, a recent study has described increased tolerance to ischemia-reperfusion in mice not expressing GC-A receptors (15).
Despite the evidence that cGMP may influence cell survival during myocardial ischemia, little is known about the consequences of ischemia on cGMP synthesis in cardiomyocytes or endothelial cells. We have recently described a marked reduction of cGMP content in rat and pig myocardium after transient sublethal ischemia (14, 29). However, other authors have reported increases (5, 21) or no change (25) in cGMP content in rat hearts submitted to up to 30 min of ischemia. To our knowledge, there are no previous reports on the effects of ischemia on cGMP synthesis in coronary microvascular cells. In vitro studies with purified GC have shown that the sensitivity of these enzymes to agonists, their rate of dissociation and rate of deactivation are strongly dependent on changes in the ionic composition of the media (3, 23). As ischemia induces a myriad of changes in cytosolic composition with different and often opposed actions on GC activity (6, 17, 22, 27, 35), it is impossible to predict its effects on cGMP synthesis in intact cells from in vitro assays of enzymatic activity.
This study was designed to analyze the effects of ischemia-reperfusion on enzymes regulating intracellular cGMP concentration in microvascular coronary endothelial cells. Because cGMP may have different and even opposed effects on endothelial cells of different origins (12), the experiments were carried out in endothelial cell cultures prepared from whole rat hearts and containing mainly endothelial cells of microvascular origin. Changes in sGC- and mGC-mediated cGMP synthesis were investigated by analyzing the response of intact cell cultures and fractionated cellular homogenates to NO donors, S-nitroso-N-acetyl-penicillamine (SNAP) or sodium nitroprussiate (SNP), and to urodilatin, respectively. Urodilatin is an ANP-related peptide that has been shown to limit myocardial necrosis secondary to ischemia-reperfusion in a variety of models including the in situ pig heart (14, 29). The contributions of ATP depletion and acidosis to the observed effects of ischemia on cGMP synthesis were also investigated.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
The care and use of animals conformed with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, Revised 1996) and the experimental procedures were approved by the Research Commission on Ethics of Hospital Vall d'Hebron.
Microvascular endothelial cells. Endothelial cells from the heart were isolated as previously described by Piper et al. (30). Two hearts from adult male Sprague-Dawley rats (250-350 g) were retrogradely perfused in a Langendorff system with collagenase, chopped, and dissolved into a suspension. From this suspension, the fraction of endothelial cells was purified and plated on a 100-mm petri dish. The culture medium consisted of medium 199 with Earle's salts, supplemented with 50 IU/ml penicillin G, 50 µg/ml streptomycin, 0.5 µg/ml amphotericin B, and 20% (vol/vol) serum (1:1 mixture of fetal bovine serum and newborn calf serum). Four hours after being plated, nonattached cells were removed by vigorous shaking. At confluency (4 days after seeding), cells were subcultivated on 60-mm dishes (2 × 104/cm2). After 3-4 days, serum content of the culture medium was progressively reduced (5% 6-8 h, 1% overnight), and dishes were used in experiments. Endothelial cells represented >95% of total cell number in confluent cultures.
Simulated ischemia and reperfusion. Cells were allocated to one of the following treatments: 1) normoxia, incubation in HEPES-buffered saline [containing (in mM) 120 NaCl, 3.6 KCl, 1.2 MgSO4, 1 CaCl2, 20 HEPES, and 5 glucose] at pH 7.4; and 2) simulated ischemia, incubation in the same buffer under 100% N2 atmosphere but without glucose and at pH 6.4. To assess the relative contributions of oxygen deprivation and acidosis to the observed effects of simulated ischemia, cells were exposed for 2 h to 3) hypoxia at pH 7.4 or to 4) normoxia at pH 6.4. The time course of recovery after restoration of normoxia and pH 7.4 was analyzed in cultures exposed for 2 h to the different treatments. PO2 in hypoxic media was 6.5 ± 1.3 mmHg after 30 min of incubation and 3.6 ± 1.0 mmHg after 2 h. In additional experiments, hypoxia was replaced by exposure to dinitrophenol (DNP; 200 µM) during 40 min.
Measurement of cGMP synthesis. After different periods of exposure to the allocated treatment, cells were stimulated for 1 min (unless otherwise indicated) with SNAP (100 µM), urodilatin (1 µM), or no drug. cGMP degradation was inhibited by the addition of 3-isobutyl-1-methylxanthine (IBMX) at 1 mM during the stimulation period. In additional experiments, the potential effect of the degradation product of SNAP on cGMP synthesis was investigated by stimulation with N-acetyl-D,L-penicillamine (100 µM). Ethanol extracts from the cell cultures were dried and resuspended in acetate buffer (5 mM, pH 4.8), and cGMP was quantified by radioimmunoassay using acetylated [3H]cGMP (2). Intracellular cGMP content after the different incubation conditions was always referred as a percentage of the cGMP content in cells of the same batch stimulated in the same way under normoxia at pH 7.4.
Measurement of intracellular pH. Changes in intracellular pH were measured with a ratiofluorescence imaging system (QuantiCell 2000, Visitech) in endothelial cells exposed for 2 h to hypoxia (pH 7.4) or acidotic normoxia (pH 6.4) and then switched to normoxia at pH 7.4. Before the experiment, cells were loaded (30 min, 37°C) with 1 µM of the acetoxymethyl ester of 2',7'-bis(2-carboxyethyl)-5,6-carboxy-fluorescein (BCECF) in medium 199 containing 1% fetal calf serum, washed, and incubated for 20 min to allow hydrolysis of the ester within the cells. Fluorescent images at 450 to 490 nm were obtained, and the average ratio for regions of interest was calculated as the quotient between fluorescence at 450 and 490 nm. Calibration of the BCECF ratio signal was performed with 10 µg/ml nigericin, a K+/H+ ionophore, and incubation of the cells with various pH (20).
ATP content and lactate dehydrogenase release. ATP content was measured in cell cultures immediately frozen in N2 liquid by means of a Bioluminescent Somatic Cell Assay Kit. Lactate dehydrogenase (LDH) activity was spectrophotometrically measured in the incubation media of cell cultures (1) and expressed as a percentage of the total LDH content in the cultures, determined after homogenization in Tris · HCl buffer.
Measurement of sGC and mGC activities.
Cell cultures were homogenated with buffer A [containing
(in mM) 50 Tris · HCl (pH 7.4), 250 sucrose, 1 EDTA, 1 dithiothreitol, plus protease inhibitors (2), the protein
kinase inhibitor staurosporin (1 × 10
3),
and the Ser/Thr protein phosphatase inhibitors okadaic acid (1 × 10
3) and cypermethrin (5 × 10
4)] in a Potter-Elvehjem homogenizer. After
centrifugation (100,000 g for 1 h), sGC activity
was determined by incubating the soluble extract with no addition
(basal), 100 µM SNP, or 100 µM SNAP in assay buffer [final
concentrations (in mM) 50 Tris · HCl (pH 7.4), 1 EGTA, 1 dithiothreitol, 1 GTP, 1 MgCl2, 10 phosphocreatine, and 1 IBMX, plus 50 U/ml creatine kinase] at 37°C for 10-20 min. In
separate experiments, the potential effect of the degradation product
of SNAP on sGC activity was investigated by incubating soluble extracts
with N-acetyl-D,L-penicillamine (100 µM). mGC activity was measured in the particulate fraction,
rehomogenized with buffer A plus 10% glycerol, in the same
assay buffer plus no addition (basal), 1 µM urodilatin, or 0.1%
Triton X-100. Natriuretic factors have been shown to scarcely stimulate
mGC after cellular homogenization (19), whereas Triton
X-100 is known to elicit a marked enhancement of mGC activity
(17). Reactions were terminated by the addition of 1 ml of
cold ethanol, and cGMP produced by enzyme activity was determined by
radioimmunoassay as described before. In these conditions, the
formation of cGMP was linear with time for at least 30 min. In the
experiments measuring the pH dependence of GC activity,
Tris · HCl buffer was substituted by 30 mM PIPES (pH
6.0-6.8) or 30 mM HEPES (pH 6.8-8.0).
Data analysis and statistics. Statistical analysis was carried out by means of commercially available software (SPSS 8.0.0). Differences between groups were evaluated by means of a one-way ANOVA. Individual comparisons between groups were performed using the Student-Newman-Keuls test. A critical P value of 0.05 was used. Values are expressed as means ± SE.
Materials. Urodilatin was kindly provided by Prof. Dr. Wolf-Georg Forssmann and Dr. Markus Meyer from Niedersächsisches Institut für Peptid-Forschung, Hannover, Germany. SNAP, SNP, DNP, N-acetyl-cysteine (NAC), IBMX, Tris, HEPES, PIPES, and the Bioluminiscent Somatic Cell Assay Kit were from Sigma; [3H]cGMP (35 Ci/mmol) was from New England Nuclear; collagenase was from Serva; Mn(III)tetrakis(4-benzoic acid)porphyrin chloride (MnTBAP) was from Calbiochem, BCECF was from Molecular Probes, plastic petri dishes were from Falcon, and culture media and sera were from GIBCO-BRL.
| |
RESULTS |
|---|
|
|
|---|
Stimulation of cGMP synthesis in normoxic endothelial cells.
Stimulation of normoxic endothelial cells for 10 min with urodilatin (1 µM) in the presence of IBMX showed a marked, sustained increase in
the cGMP content (Fig. 1A).
Stimulation with SNAP (100 µM) for 10 min caused a moderate,
transient increase in cGMP content with a peak at 1 min of stimulation
(Fig. 1C). Stimulation with
N-acetyl-D,L-penicillamine, the SNAP
degradation product, had only a minimal effect on cGMP synthesis
(0.16 ± 0.03 pmol/mg protein in stimulated cultures vs. 0.09 ± 0.01 pmol/mg protein in controls, n = 2). The
magnitude of the response to urodilatin after 1 min of stimulation was
10 times higher than the response to SNAP. This duration of stimulation
(1 min) was used for all subsequent experiments.
|
Effect of simulated ischemia and reperfusion on cGMP
synthesis.
The cellular content of cGMP in the absence of stimulation or after
stimulation with urodilatin or SNAP was not significantly modified
after 120 min of normoxic incubation (94 ± 6%, 102 ± 7%,
and 112 ± 8%, respectively, of preincubation values). Simulated ischemia (hypoxia at pH 6.4) exerted a rapid and profound
inhibitory effect on cGMP content in unstimulated and on urodilatin- or
SNAP-stimulated cells (Fig.
2A). Simulated reperfusion
allowed the complete and rapid recovery of cGMP synthesis after
stimulation of mGC by urodilatin, a partial recovery of cGMP synthesis
after stimulation by SNAP, and no significant improvement of cGMP
synthesis in unstimulated cells (Fig. 2B).
|
Role of acidosis, hypoxia, and reoxygenation.
Incubating cells in normoxic conditions at pH 6.4 (acidosis) decreased
intracellular pH to ~6.4 in <30 min (Fig.
3A). After restoration of
extracellular pH, intracellular pH rapidly recovered (Fig.
3B). Acidosis mimicked the depressant effect of simulated ischemia on cGMP synthesis (Fig.
4A). Recovery of urodilatin- and SNAP-stimulated cGMP synthesis after 120 min under acidosis was
almost complete 10 min after restoration of pH 7.4.
|
|
|
Role of energy depletion.
Acidosis had no effect on ATP content. Two hours of simulated
ischemia reduced ATP by 65% (P < 0.05; Table
1). Hypoxia at pH 7.4 induced the same
reduction (by 64% of basal) and reduced the responses to urodilatin
and SNAP by ~40%. After 40 min of exposure to DNP (200 µM), ATP
content in these cells was 16.5% of the normoxic value (Table
2), and the response of cGMP synthesis to
stimulation with urodilatin or SNAP fell to 15.3 ± 7.9% and 13.0 ± 6.2% of the normoxic responses, respectively
(P < 0.05; Table 2). Thus, in the absence of acidosis,
there was a correlation between ATP content and cGMP synthesis.
|
|
Role of oxidative stress.
The response to urodilatin was not significantly influenced by
pretreatment with NAC either in cells exposed to 120 min of normoxia or
120 min of hypoxia or to 120 min of hypoxia and 1 min of reoxygenation
(Fig. 6A). The response to
SNAP showed a trend to be potentiated by NAC. During reoxygenation,
this effect, although very small (only 5% of the reduction observed in
the SNAP response at reoxygenation could be reversed by NAC
pretreatment), reached statistical significance (Fig. 6B).
Additional series of experiments were performed in which the
cell-permeable superoxide dismutase mimetic MnTBAP at 200 µM was
present in all the incubation media. No changes were observed in the
effects of hypoxia-reoxygenation on cGMP synthesis (data not shown).
|
Effects of hypoxia and acidosis on GC activity.
When the activities of GCs from cell cultures exposed to hypoxia and/or
acidosis were measured in particulate and soluble fractions at standard
conditions (see MATERIALS AND METHODS) and pH 7.4, no
significant differences were observed respect to the activities
measured in the corresponding fractions obtained from control cultures
(normoxia at pH 7.4) (Fig. 7). Neither
sGC or mGC activities were altered by reoxygenation (data not shown).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The present study shows that nonlethal simulated ischemia (hypoxia plus acidosis) induces a dramatic reduction in cGMP content in coronary microvascular endothelial cells and in the ability of these cells to synthesize cGMP in response to stimulation of sGC or mGC. Acidosis alone is able to mimic this rapid and profound effect of simulated ischemia, whereas hypoxia per se produces a partial and comparatively slow decrease in cGMP synthesis. The inhibitory effect of hypoxia and/or acidosis on the response to stimulation of mGC with urodilatin completely reversed after restoration of initial conditions. However, the inhibition of sGC-dependent cGMP synthesis induced by hypoxia was transiently aggravated upon reoxygenation and reversed only partially thereafter.
Previous studies.
To our knowledge, no previous studies have analyzed the effects of
simulated ischemia or hypoxia on the ability of coronary microvascular endothelial cells to synthesize cGMP, and information about how simulated ischemia affects cGMP synthesis in related vascular or myocardial cells is scant. In a previous study
(32), hypoxia did not affect cGMP content in either
unstimulated or atriopterin II-stimulated aortic endothelial cells. The
discrepancy between that study and the present results could be
explained by the different behavior between macrovascular and
microvascular endothelial cells (12) or by the milder
degree of hypoxia in the previous work (14.4% O2) compared
with the present one. In support of this latter explanation, we found
no effects of hypoxia on either mGC- or sGC-mediated cGMP synthesis
with oxygen concentrations
10% (unpublished results). In pulmonary
arteries, moderate hypoxia (30-45 mmHg) impaired the synthesis of
endothelium-derived relaxing factor without affecting cGMP synthesis
elicited by direct stimulation of sGC with SNP (16, 33,
34), whereassevere hypoxia (3 mmHg) evoked partial inhibition of
smooth muscle sGC (33).
Role of acidosis. This study demonstrates for the first time the profound depressant effect of acidosis on cellular cGMP synthesis. This effect accounted for the depression of cGMP synthesis observed during the initial phase of simulated ischemia (hypoxia plus acidosis) in microvascular endothelial cells when severe ATP depletion has not yet occurred. After 30 min of oxygen deprivation, cGMP synthesis is not depressed in the absence of concomitant acidosis but is severely depressed in its presence. The present results also suggest that this effect of acidosis is due to a direct effect of low pH on GC activity. First, there was a good correlation between the time course of cGMP inhibition and the time course of intracellular pH decrease during exposure to extracellular buffer at pH 6.4. Second, in agreement with previous studies (9), both mGC and sGC enzymatic activities were extremely low at pHs below 6.8, a value that the intracellular pH reached within 30 min of exposure to extracellular acidosis. Third, recovery of cGMP synthesis was rapid after exposure to transient acidosis, and its time course correlated very well with the time course of normalization of intracellular pH.
Hypoxia and energy depletion. After 2 h of hypoxia, both nonstimulated and stimulated cGMP synthesis decreased to ~50% of the value under normoxic conditions. This value correlates well with the reduction in intracellular ATP content at that time (~50% of the value in normoxic cells). When severe ATP depletion was induced by metabolic inhibition with DNP instead of oxygen deprivation, the correlation was maintained, suggesting that in coronary microvascular endothelial cells, cGMP synthesis is closely related with ATP availability. Although the ATP concentration determines that of GTP, the substrate for sGC and mGC, this relation between ATP concentration and cGMP synthesis could not have been easily anticipated. Other effects of ATP depletion can modulate the consequences of reduced GTP concentration. ATP depletion results in a concomitant increase in intracellular Mg2+ and inorganic phosphate concentrations (27, 35). Because the substrate used by sGC and mGC is Mg2+-GTP and phosphate stimulates mGC (27), the increase in Mg2+ and phosphate tends to antagonize the effects of ATP depletion on cGMP synthesis. Furthermore, stimulatory and inhibitory sites for ATP have been described in both the A and B types of mGC (6, 17, 22). Finally, energy depletion may also affect mGC activity through modifications in its phosphorylation state (22). However, this latter mechanism seems irrelevant in microvascular endothelial cells because no changes in mGC or sGC activities were observed in cell fractions obtained from cultures exposed to hypoxia.
As referred to above, different authors have described divergent effects of hypoxia on cGMP synthesis. In fact, most authors do not find an inhibitory effect of hypoxia. Considering the complex relationship between ATP depletion and cGMP synthesis described above, it seems plausible that small differences in the degree of hypoxia or even in the ratio between the distinct enzyme subtypes (both for sGC and mGC) result in the divergent results found by different authors. Our results demonstrate that both acidosis and ATP depletion are sufficient to profoundly inhibit cGMP synthesis. The severe depressant effects of the degree of acidosis used in this study (pH 6.4) precluded to assess whether the effects of low pH and deenergization are additive.Additional injury during reoxygenation. Reoxygenation allowed a slow but complete recovery of the response to urodilatin after 120 min of hypoxia at pH 7.4 despite minimal ATP recovery. In contrast, cGMP synthesis in response to stimulation with SNAP suffered a transient and acute decrease upon reoxygenation, which was partially reversed afterward. sGC has been shown to be very sensitive to changes in the redox state of the cell, and the burst of oxygen free radicals during the first minute of reoxygenation could explain the transient inhibitory effect on SNAP stimulation. However, pretreating the cells with NAC or incubating them with a superoxide dismutase mimetic did not substantially modify the inhibitory effect evoked by reoxygenation. sGC-mediated responses can be modulated by changes in the phosphorylation state (7). Nevertheless, none of these mechanisms seems to play a relevant role in our study because no changes were observed in sGC activity in the soluble fraction obtained from cell cultures submitted to transient hypoxia. The identification of the precise mechanisms involved in the genesis of this phenomenon escapes from the goals of the present study.
Limitations. This study was focused on only two of the many intracellular changes induced by ischemia: ATP depletion and intracellular acidosis. These two changes are, however, of the greatest relevance, and their effects on cGMP synthesis observed in this study are consistent with recent observations in rat and pig myocardium submitted to severe ischemia (14, 29). On the other hand, many of the effects of ischemia or hypoxia consist in alterations of the intracellular environment, such as ionic composition or redox state, that cannot be observed with the "classical" assay of enzymatic activity (involving cell disruption) used in this study. However, the extremely high cGMP concentrations reached after exogenous stimulation of sGC or mGC render potential interferences by endogenous substances like NO irrelevant, making it possible to estimate the intracellular activities of mGC and sGC.
Implications. Although altered cGMP synthesis was not associated to cell death in microvascular coronary endothelial cultures, cGMP in endothelial cells is known to modulate events that can contribute to myocardial injury. The present study demonstrates that reduced ability to synthesize cGMP may be an important element in the pathophysiology of ischemia-reperfusion injury. On the other hand, the depressant effect of ischemia on cGMP synthesis could explain the reduced susceptibility to cGMP-mediated apoptosis recently observed in postischemic myocardium (unpublished observations and Ref. 36). Together with previous work showing the protective effect of cGMP against cell death during myocardial reperfusion, the present results should serve as a basis for the development of new pharmacological strategies for the protection of the postischemic myocardium.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Yolanda Puigfel and Angeles Rojas for excellent technical work.
| |
FOOTNOTES |
|---|
This study was supported by Comisión Interministerial de Ciencia y Tecnología Grant SAF99/0102.
Address for reprint requests and other correspondence: D. García-Dorado, Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Passeig Vall d'Hebron, 119-129, 08035 Barcelona, Spain (E-mail: dgdorado{at}hg.vhebron.es).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
May 2, 2002;10.1152/ajpheart.01067.2001
Received 5 December 2001; accepted in final form 29 April 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Agulló, L,
García-Dorado D,
Inserte J,
Paniagua A,
Pyrhonen P,
Llevadot J,
and
Soler-Soler J.
L-Arginine limits myocardial cell death secondary to hypoxia-reoxygenation by a cGMP-dependent mechanism.
Am J Physiol Heart Circ Physiol
276:
H1574-H1580,
1999
2.
Baltrons, MA,
Saadoun S,
Agulló L,
and
García A.
Regulation by calcium of the nitric oxide/cyclic GMP system in cerebellar granule cells and astroglia in culture.
J Neurosci Res
49:
333-341,
1997[ISI][Medline].
3.
Bellamy, TC,
Wood J,
Goodwin DA,
and
Garthwaite J.
Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses.
Proc Natl Acad Sci USA
97:
2928-2933,
2000
4.
Butt, E,
Bernhardt M,
Smolenski A,
Kotsonis P,
Fröhlich LG,
Sickmann A,
Meyer HE,
Lohmann SM,
and
Schmidt HHHW
Endothelial nitric-oxide synthase (type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases.
J Biol Chem
275:
5179-5187,
2000
5.
Depré, C,
and
Hue L.
Cyclic GMP in the perfused heart. Effect of ischaemia, anoxia and nitric oxide synthase inhibitor.
FEBS Lett
345:
241-245,
1994[ISI][Medline].
6.
Duda, T,
Goraczniak R,
and
Sharma RK.
Distinct inhibitory ATP-regulated modulatory domain (ARMi) in membrane guanylate cyclases.
Biochem J
319:
279-283,
1996[Medline].
7.
Ferrero, R,
Rodríguez-Pascual F,
Miras-Portugal MT,
and
Torres M.
Nitric oxide-sensitive guanylyl cyclase activity inhibition through cyclic GMP-dependent dephosphorylation.
J Neurochem
75:
2029-2039,
2000[ISI][Medline].
8.
Feuerstein, GZ,
and
Young PR.
Apoptosis in cardiac diseases: stress- and mitogen-activated signaling pathways.
Cardiovasc Res
45:
560-569,
2000[ISI][Medline].
9.
Grabow, M,
Chakraborty G,
and
Ledeen RW.
Characterization of guanylyl cyclase in purified myelin.
Neurochem Res
21:
457-462,
1996[ISI][Medline].
10.
Gross, SS,
and
Wolin MS.
Nitric oxide: pathophysiological mechanisms.
Annu Rev Physiol
57:
737-769,
1995[ISI][Medline].
11.
Heller, R,
Bussolino F,
Ghigo D,
Pescarmona GP,
Calvino R,
Gasco A,
Till U,
and
Bosia A.
Activation of endothelial guanylate cyclase inhibits cellular reactivity.
Agents Actions Suppl
45:
177-181,
1995[Medline].
12.
Hempel, A,
Noll T,
Muhs A,
and
Piper HM.
Functional antagonism between cAMP and cGMP on permeability of coronary endothelial monolayers.
Am J Physiol Heart Circ Physiol
270:
H1264-H1271,
1996
13.
Hoshida, S,
Yamashita N,
Kawahara K,
Kuzuya T,
and
Hori M.
Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis. Possible mechanisms.
Circulation
99:
434-440,
1999[ISI][Medline].
14.
Inserte, J,
García-Dorado D,
Agulló L,
Paniagua A,
and
Soler-Soler J.
Urodilatin limits acute reperfusion injury in the isolated rat heart.
Cardiovasc Res
45:
351-359,
2000[ISI][Medline].
15.
Izumi, T,
Saito Y,
Kishimoto I,
Harada M,
Kuwahara K,
Hamanaka I,
Takahashi N,
Kawakami R,
Li Y,
Takemura G,
Fujiwara H,
Garbers DL,
Mochizuki S,
and
Nakao K.
Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-
B activation and alleviates myocardial ischemia/reperfusion injury.
J Clin Invest
108:
203-213,
2001[ISI][Medline].
16.
Johns, RA,
Linden JM,
and
Peach MJ.
Endothelium-dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia.
Circ Res
65:
1508-1515,
1989[Abstract].
17.
Kimura, H,
and
Murad F.
Localization of particulate guanylate cyclase in plasma membranes and microsomes of rat liver.
J Biol Chem
250:
4810-4817,
1975
18.
Kubes, P.
Nitric oxide-induced microvascular permeability alterations: a regulatory role for cGMP.
Am J Physiol Heart Circ Physiol
265:
H1909-H1915,
1993
19.
Kurose, H,
Inagami T,
and
Ui M.
Participation of adenine 5'-triphosphate in the activation of membrane-bound guanylate cyclase by the atrial natriuretic factor.
FEBS Lett
219:
375-379,
1987[ISI][Medline].
20.
Ladilov, Y,
Schäfer C,
Held A,
Schäfer M,
Noll T,
and
Piper HM.
Mechanism of Ca2+ overload in endothelial cells exposed to simulated ischemia.
Cardiovasc Res
47:
394-403,
2000[ISI][Medline].
21.
Lochner, A,
Genade S,
Tromp E,
Opie L,
Moolman J,
Thomas S,
and
Podzuweit T.
Role of cyclic nucleotide phosphodiesterases in ischemic preconditioning.
Mol Cell Biochem
186l:
169-175,
1998.
22.
Lucas, KA,
Pitari GM,
Kazerounian S,
Ruiz-Stewart I,
Park J,
Schulz S,
Chepenik KP,
and
Waldman SA.
Guanylyl cyclases and signaling by cyclic GMP.
Pharmacol Rev
52:
375-413,
2000
23.
Margulis, A,
and
Sitaramayya A.
Rate of deactivation of nitric oxide-stimulated soluble guanylate cyclase: influence of nitric oxide scavengers and calcium.
Biochemistry
39:
1034-1039,
2000[Medline].
24.
Matsumoto, H,
Hirai R,
Uemura T,
Ota T,
Urakami A,
and
Shimizu N.
Experimental evaluation of the effects of the intraportal administration of cyclic guanosine monophosphate on ischemia/reperfusion in the porcine liver.
Surg Today
29:
1158-1163,
1999[ISI][Medline].
25.
Maulik, N,
Engelman DT,
Watanabe M,
Engelman RM,
Maulik G,
Cordis GA,
and
Das DK.
Nitric oxide signaling in ischemic heart.
Cardiovasc Res
30:
593-601,
1995[ISI][Medline].
26.
Murohara, T,
Scalia R,
and
Lefer AM.
Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors.
Circ Res
78:
780-789,
1996
27.
Nashida, T,
Imai A,
and
Shimomura H.
Regulation of ANP-stimulated guanylate cyclase in the presence of Mn2+ in rat lung membranes.
Mol Cell Biochem
208:
27-35,
2000[ISI][Medline].
28.
Nesher, R,
Robinson WF,
Gibb L,
Bishop SP,
and
Kruger FA.
Cyclic nucleotide levels in the perfused rat heart subjected to hypoxia.
Experientia
33:
215-217,
1977[ISI][Medline].
29.
Padilla, F,
García-Dorado D,
Agulló L,
Barrabés JA,
Inserte J,
Escalona N,
Meyer M,
Mirabet M,
Pina P,
and
Soler-Soler J.
Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs.
Cardiovasc Res
51:
592-600,
2001[ISI][Medline].
30.
Piper, HM,
Spahr R,
Mertens S,
Krützfeldt A,
and
Watanabe H.
Microvascular endothelial cells from heart.
In: Cell Culture Techniques in Heart and Vessel Research, edited by Piper HM.. Berlin, Germany: Springer-Verlag, 1990, p. 159-177.
31.
Rakhit, RD,
Edwards RJ,
and
Marber MS.
Nitric oxide, nitrates and ischemic preconditioning.
Cardiovasc Res
43:
621-627,
1999[ISI][Medline].
32.
Richards, JM,
Gibson IF,
and
Martin W.
Effects of hypoxia and metabolic inhibitors on production of prostacyclin and endothelium-derived relaxing factor by pig aortic endothelial cells.
Br J Pharmacol
102:
203-209,
1991[ISI][Medline].
33.
Rodman, DM,
Yamaguchi T,
Hasunuma K,
O'Brien RF,
and
McMurtry IF.
Effects of hypoxia on endothelium-dependent relaxation of rat pulmonary artery.
Am J Physiol Lung Cell Mol Physiol
258:
L207-L214,
1990
34.
Shaul, PW,
Farrar MA,
and
Zellers TM.
Oxygen modulates endothelium-derived relaxing factor production in fetal pulmonary arteries.
Am J Physiol Heart Circ Physiol
262:
H355-H364,
1992
35.
Silverman, HS,
Di Lisa F,
Hui RC,
Miyata H,
Sollott SJ,
Hanford RG,
Lakatta EG,
and
Stern MD.
Regulation of intracellular free Mg2+ and contraction in single adult mammalian cardiac myocytes.
Am J Physiol Cell Physiol
266:
C222-C233,
1994
36.
Taimor, G,
Hofstaetter B,
and
Piper HM.
Apoptosis induction by nitric oxide in adult cardiomyocytes via cGMP-signaling and its impairment after simulated ischemia.
Cardiovasc Res
45:
588-594,
2000[ISI][Medline].
37.
Weyrich, AS,
Ma X,
and
Lefer AM.
The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat.
Circulation
86:
279-288,
1992[ISI][Medline].
38.
Yamaguchi, F,
Nasa Y,
Yabe K,
Ohba S,
Hashizume Y,
Ohaku H,
Furuhama K,
and
Takeo S.
Activation of cardiac muscarinic receptor and ischemic preconditioning effects in in situ rat heart.
Heart Vessels
12:
74-83,
1997[ISI][Medline].
This article has been cited by other articles:
![]() |
D. Garcia-Dorado, A. Rodriguez-Sinovas, M. Ruiz-Meana, J. Inserte, L. Agullo, and A. Cabestrero The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion Cardiovasc Res, May 1, 2006; 70(2): 274 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Christou, N. Bailey, M. S. Kluger, S. A. Mitsialis, and S. Kourembanas Extracellular acidosis induces heme oxygenase-1 expression in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2647 - H2652. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bertuglia and A. Giusti Role of nitric oxide in capillary perfusion and oxygen delivery regulation during systemic hypoxia Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H525 - H531. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bertuglia and A. Giusti Microvascular oxygenation, oxidative stress, NO suppression and superoxide dismutase during postischemic reperfusion Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1064 - H1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Agullo, D. Garcia-Dorado, N. Escalona, M. Ruiz-Meana, J. Inserte, and J. Soler-Soler Effect of ischemia on soluble and particulate guanylyl cyclase-mediated cGMP synthesis in cardiomyocytes Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2170 - H2176. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bertuglia and A. Giusti Role of nitric oxide in capillary perfusion and oxygen delivery regulation during systemic hypoxia Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H525 - H531. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |